Anemia hemolítica auto-imune como sintoma inicial de linfoma de hodgkin

Oliveira, Maria Christina Lopes A; Oliveira, Benigma Maria; Fernandes, Rachel Aparecida Ferreira; Murao, Mitiko; Paes, Cybele de Andrade; Ramos, Gilberto; Antunes, Vivian P; Viana, Marcos Borato.
Rev. méd. Minas Gerais ; 17(1/2): 64-67, jan.-jun. 2007.
Artículo en Portugués | LILACS | ID: lil-556275

Documentos relacionados

  1. Ultrastructural analysis of nucleated erythrocyte in patients with autoimmune hemolytic anemia (AIHA).
  2. The potential of metabolomics as a predictive guide for clinical management in autoimmunity against red blood cells.
  3. A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome.
  4. Warm autoimmune hemolytic anemia: new insights and hypotheses.
  5. Possible role of IL-23 inhibitor in autoimmune hemolytic anemia.
  6. Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow-up.
  7. Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.
  8. Primary cold agglutinin disease: a recently recognised diagnostic entity in WHO and ICC.
  9. Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD).
  10. Outcomes of therapeutic plasma exchange in severe autoimmune hemolytic anemia hospitalizations: An analysis of the National Inpatient Sample.